Orchid Pharma shares hit 52-week high on raising ₹400 cr via QIP
Investors who have been allotted over 5% equity shares are MIT (23.75%), Quant’s Multi-Asset Fund (12.75%) and Value Fund (6.75%), Carnelian Structural Shift Fund (6.25%) and Societe Generale (6%)
